BDBM612281 N-(4-([1,2,4]triazolo[1,5- c]pyrimidin-7-yloxy)-3- methylphenyl)-5-(2-(2,2- difluoroethyl)-2,6- diazabicyclo[3.2.0]heptan-6-yl)-6- methoxyquinazolin-4-amine::US11723908, Example 68

SMILES COc1ccc2ncnc(Nc3ccc(Oc4cc5ncnn5cn4)c(C)c3)c2c1N1CC2C1CCN2CC(F)F

InChI Key InChIKey=FXPULUWIDCEJPG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 612281   

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM612281(US11723908, Example 68 | N-(4-([1,2,4]triazolo[1,5...)
Affinity DataIC50: 6.40nMAssay Description:Inhibition of phosphor HER2 was determined by enzyme-linked immunosorbent assay (ELISA) in BT474 cells. BT474 cell line was purchased from ATCC (cata...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2023
Entry Details
Go to US Patent